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ABSTRACT
Introduction: Type 2 diabetes represents a sig-
nificant public health issue, with increasing
prevalence in developing countries while
adherence to insulin treatment remains a chal-
lenge. No studies have evaluated the relation-
ship between adherence to insulin, diabetes-
related distress, and trust in physician among
persons with diabetes. Our objectives were to
evaluate treatment adherence to insulin,
emotional distress (using the Problem Areas in
Diabetes Questionnaire, PAID), trust in physi-
cian, and to examine associations between
them among Lebanese patients with diabetes.
Methods: This cross-sectional study, conducted
in all districts of Lebanon between August 2016
and April 2017, enrolled 135 adult patients.
Results: The mean percentage score of adher-
ence to insulin was 79.7 ± 19.94. A significantly
higher mean adherence score was found in non-
sedentary (81.96) compared to sedentary
patients (67.41) (p = 0.017), with no difference
between gender, employment, rural vs non-rural
residence, or familial history of diabetes. In
addition, no significant relationship was seen
between adherence score and education level,
smoking, or alcohol intake. A significant positive
associationwas found between trust in physician
and adherence scores, whereas a significant but
negative one was found between PAID and
adherence scores. The results of linear regressions
showed that a secondary level of education (beta
= - 13.48) significantly decreased the trust in
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physician score, whereas the total number of oral
antidiabetics (beta = 0.93) increased it. Having a
sedentary lifestyle (beta = - 12.73) and smoking
\ 3 waterpipes/week compared to no smoking
(beta = - 16.82) significantly decreased the
adherence score. Female gender (beta = 10.46),
smoking\ 3 waterpipes (beta = 27.42) and 3 ?
waterpipes/week (beta = 17.95) significantly
increased the PAID score.
Conclusion: Trust in physician is associated
with an increased adherence and with decreased
diabetes-related distress. This distress was also
associated with poor adherence in our study.
Keywords: Adherence; Diabetes; Emotional
distress; Insulin; Trust in physician
INTRODUCTION
Every 6 s, a person dies in the world because of
diabetes [1]. According to the latest report of the
World Health Organization (WHO), type 2 dia-
betes (T2D) will be the seventh leading cause of
death by 2030 [2]. Also, T2D presents a partic-
ularly high prevalence in both the Middle East
and North Africa; among these regions, Leba-
non occupies seventh place with a rate of 16.3%
[1].
According to the WHO, adherence to treat-
ment may be defined as the extent to which the
patient’s history of therapeutic drug-taking
coincides with the prescribed treatment [3].
Adherence to treatment remains a challenge in
T2D since it is a chronic illness that is associated
with a risk of comorbidity and requires a life-
style change, especially after the onset of insu-
lin therapy [4].
Even though insulin remains the most
effective therapy to lower glycemia, the
American Diabetes Association and the
National Institute for Health and Clinical
Excellence (NICE) guidelines recommend using
insulin as a last resort, after several failures to
achieve glycemic control with an oral glucose-
lowering agent [5–7].
Low insulin adherence leads to poor gly-
cemic control and may exacerbate microvascu-
lar and macrovascular complications such as
kidney disease, dyslipidemia, stroke, retinopa-
thy, nephropathy, and neuropathy and may
increase episodes of hypoglycemia [8]. In fact,
45% of patients with T2D fail to achieve a good
glycemic control [6].
Furthermore, according to several studies,
diabetes may cause emotional distress which
probably has an influence on medication
adherence. Emotional distress is associated with
depression, patient fears, and a lack of social
and family support [9, 10].
In addition, trust in the healthcare provider
is one of the central pillars of a patient–physi-
cian relationship. Previous studies conducted
among adults with diabetes showed that
increased trust in one’s physician has been
associated with better glycemic control [11, 12].
The quality of information exchange and of
primary care relationships are affected by the
patient and provider communication behaviors
[13]. In the short term, communicating with
the patient can enhance trust in the physician,
who will be able to incorporate treatment
decisions according to the patient’s preferences
and needs [13]. In addition, Schoenthaler et al.
suggested that the quality of the
patient–physician relationship has a strong
influence on adherence to medication [14]. A
better relationship contributes to the patients’
engagement in their care, which further influ-
ences outcomes related to self-care [15]. Con-
versely, when patients do not have confidence
in their healthcare provider, they are less likely
to implement care recommendations and thus
to be adherent to their prescribed treatment
[16].
Previous findings have suggested that high
levels of diabetes-specific distress may account
for higher functional impairment, work
loss, and poorer self-management behavior
[17–19]. Decreasing emotional distress is
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important in helping the patient with diabetes
to cope with the disease and improving adher-
ence to treatment [3]. Furthermore, Fisher et al.
[20] identified seven major sources of distress
among patients with type 1 diabetes, among
them physician distress. This finding led us to
hypothesize that trust may be a factor that
contributes to physician-related diabetes dis-
tress, in type 1 as well as type 2 diabetes.
Several studies have been conducted to
detect factors associated with insulin adherence
worldwide [21–23], but none explored the
impact of trust in physician and diabetes-related
emotional distress on adherence to insulin. The
primary objective of this study was to assess
factors associated with insulin adherence
among Lebanese patients with diabetes and to
explore the relationship between this adher-
ence, the patients’ trust in their healthcare
provider, and diabetes-related emotional
distress.
METHODS
Study Design and Population
This cross-sectional study, conducted in all dis-
tricts of Lebanon, was done between August
2016 and April 2017. Our sample was con-
structed from 20 community pharmacies selec-
ted randomly. Adult patients from any gender,
with type 2 diabetes diagnosed at least
3 months ago, and treated with insulin or
insulin analogues were eligible. Patients using
an insulin pump were excluded.
Data Collection
The questionnaire was distributed by trained
interviewers. After obtaining the authorization
from each pharmacy owner, the study objec-
tives were explained to each patient after
obtaining a written consent.
The self-administered anonymous question-
naire was in Arabic, the native language in
Lebanon; it was composed of different sections:
the first part included sociodemographic (age,
gender, place of residence, marital status, and
educational level), social habits (cigarette and
waterpipe smoking, alcohol consumption),
physical activity, family history of diabetes,
duration and complications of diabetes. The
second one comprised questions about insulin:
name, dose, frequency of administration, shak-
ing the vial or not before withdrawing,
respecting the time of administration, storage,
changing the needle after use, respecting the
expiry date of the vial after opening; we also
included questions about the level of patient’s
fasting blood glucose (in the last checkup), the
frequency of monitoring, the number of hypo-
and/or hyperglycemia episodes during the last
12 months.
The scales used in this study (adherence,
trust in physician, and PAID) were translated
from English to Arabic through an initial
translation and back-translation process. The
English version was translated into Arabic by a
certified translator, then this translation was
translated again into English by another certi-
fied translator. Upon completion of this pro-
cess, the translators compared the English
versions of the scales to determine whether the
variables had the same meaning. The back
translation did not lead to any modification in
the Arabic version of any scale.
Adherence Assessment
The adherence to insulin was assessed using an
adaptation of Lu et al.’s questionnaire [24] by
asking the patients about the frequency, per-
centage, and rating response of their insulin use
during the last month. Concerning the fre-
quency, we asked the patient ‘‘did you take
insulin all the time?’’ with the possible respon-
ses being divided as follow: 0% for none of the
time, 20% for a little of the time, 40% for some
of the time, 60% for a good bit of the time, 80%
for most of the time, and 100% for all the time.
The percentage item was checked using the
question ‘‘what percent of the time were you
able to take your medications exactly as your
doctor prescribed them?’’ The rating item was
assessed using the question ‘‘rate your ability to
take all your medications as prescribed’’ with
the possible answers being divided as follows:
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0% = very poor, 20% = poor, 40% = fair,
60% = good, 80% = very good, and
100% = excellent. The total score was calcu-
lated by summing all three answers and pre-
sented in a percentage [24–26]. We calculated
the reliability of each scale to assess the quality
of our data. We obtained acceptable Cronbach
alpha (0.621). Initially, the Lu et al.’s question-
naire was validated among patients with HIV
and was later used in a population of patients
attending general practice [26].
Trust in Physician Scale
This scale is composed of 11 items (supple-
mentary file), scored on a 5-point Likert scale
ranging from 1 (strongly disagree) to 5 (strongly
agree), except for questions 1, 5, 7, and 11
where the scoring was reversed. A summary
measure of trust is obtained by taking the
unweighted mean of the responses to the 11
questions and transforming that value to a
0–100 scale. Higher scores reflect greater trust.
The wording of the 11 questions and the scoring
system for each question are presented in
Table 1. This scale was largely used among dif-
ferent participant populations and across a wide
range of pathologies [27–30]. When completing
the scale, respondents were instructed to think
of the endocrinologist who usually provided
their diabetes care [31]. We obtained high
Cronbach alpha for this scale (0.892).
Problem Areas in Diabetes Questionnaire
(PAID)
The PAID measures diabetes-related emotional
distress, which correlates with measures of
related concepts such as depression, social sup-
port, health beliefs, and coping style, as well as
predicts future blood glucose control of the
patient [32]. The PAID is a self-report pencil and
paper questionnaire that contains 20 items that
describe negative emotions related to diabetes
Table 1 Trust in physician scale questions and scoring
Totally
disagree
Disagree Neutral Agree Totally
agree
1. I doubt that my doctor really cares about me as a person 5 4 3 2 1
2. My doctor is usually considerate of my needs and puts them first 1 2 3 4 5
3. I trust my doctor so much I always try to follow his/her advice 1 2 3 4 5
4. If my doctor tells me something is so, then it must be true 1 2 3 4 5
5. I sometimes distrust my doctor’s opinions and would like a second
one
5 4 3 2 1
6. I trust my doctor’s judgments about my medical care 1 2 3 4 5
7. I feel my doctor does not do everything he/she should about my
medical care
5 4 3 2 1
8. I trust my doctor to put my medical needs above all other
considerations when treating my medical problems
1 2 3 4 5
9. My doctor is well qualified to manage (diagnose and treat or make
an appropriate referral) medical problems like mine
1 2 3 4 5
10. I trust my doctor to tell me if a mistake was made about my
treatment
1 2 3 4 5
11. I sometimes worry that my doctor may not keep the information
we discuss totally private
5 4 3 2 1
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(e.g., fear, anger, frustration) commonly expe-
rienced by patients with diabetes. Completion
takes approximately 5 min. Each question has
five possible answers with a value from 0 to 4,
with 0 representing ‘‘no problem’’ and 4 ‘‘a
serious problem’’. The scores are added up and
multiplied by 1.25, generating a total score
between 0–100. Patients scoring 40 or higher
may be at the level of ‘‘diabetes-related distress’’
and warrant special attention. An extremely low
score (0–10) combined with poor glycemic
control may be indicative of denial. The Cron-
bach alpha for the PAID scale was excellent
(0.909).
Compliance with Ethical Guidelines
The study protocol was approved by the ethics
committee of Saint-Joseph University of Beirut
(reference number: USJ-2016-55). All proce-
dures performed in studies involving human
participants were in accordance with the ethical
standards of the institutional research commit-
tee of Saint-Joseph University of Beirut and with
the 1964 Declaration of Helsinki and its later
amendments. Informed consent was obtained
from all individual participants included in the
study.
Statistical Analysis
Data were collected and processed by Statistical
Package for the Social Sciences SPSS, Version 23.
Categorical variables were presented in fre-
quencies and percentages, and continuous
variables as means with standard deviations.
Statistical analysis was conducted using Chi
square, Fisher exact t test, and analysis of vari-
ance. ANOVA and Kruskal–Wallis tests were
used to compare between three groups or more,
and Pearson correlation coefficient was used to
assess correlations between quantitative vari-
ables. In addition, a multivariate regression was
conducted to reduce confounders. A linear
regression was performed taking the adherence
to treatment as the dependent variable. Vari-
ables which gave a p value less than 0.2 in the
bivariate analysis were independent variables. A





The total number of patients included in this
study was 135 patients. The main sociodemo-
graphic characteristics of patients are presented
in Table 2.
Data Related to Clinical Characteristics
of Diabetes
The mean duration of diabetes, since diagnosis,
was 229.50 months (more than 19 years).
Seventy-one percent of patients had a family
history of diabetes and 88% were followed by a
specialist in endocrinology. Ninety-three per-
cent of patients in this study had comorbidities
with an average of two concurrent medical
conditions associated with diabetes. The results
are shown in Table 3.
Data Related to Insulin Therapy
Information regarding insulin therapy is sum-
marized in Table 4. Six different patterns of
insulin administration were observed. Most
patients, about 76%, used the regimen based on
the administration of a basal insulin alone or a
basal insulin and bolus premix. The remaining
patients were on other regimens. The majority
of patients (79%) used insulin pens.
Thirteen percent of the patients were well
controlled with an HbA1C \ 7%. Forty-nine
percent were considered to be reasonably con-
trolled with an HbA1C between 7% and 8%.
Thirty-five percent were poorly controlled
(HbA1c[8%).
Concerning the patient’s education, 88% of
the patients gave a correct answer when asked
about the normal range of fasting blood glucose
and 84% knew the target levels of HbA1C that
provide a good diabetes control (HBA1C\8%).
Furthermore, 63% of these patients were
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practicing a self-glucose monitoring test with an
average frequency of once a day.
Average Scores Obtained for Trust
in Physician Scale, PAID, and Adherence
to Insulin
The mean trust in physician score was
73.35 ± 20.38 (median = 75), whereas the mean
PAID and adherence scores were 32.75 ± 29.37
(median = 22.41) and 79.7 ± 19.94 (me-
dian = 87.5), respectively.
Bivariate Analysis
A significantly higher mean adherence score
was found in non-sedentary (81.96) compared
to sedentary patients (67.41). A significantly
higher PAID score was found in female com-
pared to male patients (37.27 vs 28.11), in
sedentary compared to non-sedentary patients
(42.38 vs 30.96). A significantly higher mean
trust in physician score was found in illiterate
patients (78.66) compared to other levels of
education, and in those who smoked below
three waterpipes weekly (55.35) compared to
other groups (Table 5).
Furthermore, a significant negative correla-
tion was found between the trust in physician
score and the PAID score (r = - 0.289) and a
positive one with the adherence score
Table 2 Patients’ sociodemographic characteristics
Sex
Male, N (%) 67 (49.6%)
Female, N (%) 68 (50.4%)
Age in years, mean (standard deviation) 65.84 (13.2)
Weight in kg, mean (standard deviation) 76.92 (16.1)
BMI (body mass index), mean (standard
deviation)
27.66 (5.5)
Less than 18.5, N (%) 5 (3.7%)
Between 18.5 and 24.9, N (%) 36 (26.7%)
Between 25 and 29.9, N (%) 51 (37.8%)
30 or more, N (%) 43 (31.9%)
Marital status
Married, N (%) 98 (72.6%)
Divorced/widower, N (%) 19 (14.1%)
Single, N (%) 18 (13.3%)
Sedentary lifestyle
Yes, N (%) 21 (15.6%)
No, N (%) 114 (84.4%)
Residence
Rural, N (%) 63 (46.7%)
Non rural, N (%) 72 (53.3%)
Working
Yes, N (%) 41 (30.4%)
No, N (%) 94 (69.6)
Level of education
Illiterate, N (%) 18 (13.3%)
Primary, N (%) 56 (41.5%)
Secondary, N (%) 26 (19.3%)
University, N (%) 35 (25.9%)
Cigarette consumption per day
Non-smoker, N (%) 64 (47.4%)
1–14 cigarettes, N (%) 14 (10.4%)
15 or more cigarettes, N (%) 25 (18.5%)
Former smoker, N (%) 32 (23.7%)
Table 2 continued
Waterpipe consumption per week
Non-smoker, N (%) 110 (81.5%)
Below 3, N (%) 7 (5.2%)
3 or more, N (%) 8 (5.9%)
Former smoker, N (%) 10 (7.4%)
Alcohol consumption per week
Non-drinker, N (%) 94 (69.6%)
Up to one time, N (%) 26 (19.3%)
More than once, N (%) 9 (6.7%)
Former drinker, N (%) 6 (4.4%)
718 Diabetes Ther (2018) 9:713–726
(r = 0.416). A significant negative correlation
was found between the PAID score and the
adherence score (r = - 0.3), duration of diabetes
since diagnosis (r = - 0.172), and the duration
of insulin therapy (r = - 0.239) (Table 6).
Multivariable Analysis
The results of a first stepwise linear regression,
taking the trust in physician score as the
dependent variable, showed that a secondary
level of education was significantly associated
with a decrease in the trust in physician score
(beta = - 13.48), whereas the total number of
oral antidiabetics was significantly associated
with an increase in that score (beta = 0.93).
A second stepwise linear regression, taking
the adherence score as the dependent variable,
showed that having a sedentary lifestyle
(beta = - 12.739) and smoking less than three
waterpipes per week compared to no waterpipe
smoking (beta = - 16.826) were significantly
associated with a decrease in the adherence
score.
A third stepwise linear regression, taking the
PAID score as the dependent variable, showed
that female gender (beta = 10.467), smoking
less than three waterpipes (beta = 27.426), and
three or more waterpipes weekly
(beta = 17.951) compared to no waterpipe
smoking were significantly associated with an
increase in the PAID score (Table 7).
DISCUSSION
To the best of our knowledge, our study is the
first to assess the adherence of patients with
diabetes type 2 to their insulin treatment and
the factors associated with this adherence, in
Lebanon. Adherence to treatment is a key
Table 3 Clinical characteristics of diabetes among
participants
Diabetes duration in months, mean
(standard deviation)
229.50 (126.02)
Family history of diabetes
Yes, N (%) 96 (71.1%)
No, N (%) 39 (28.9%)
Physician’s visit frequency






0 comorbidity, number of patients (%) 6 (4.4%)
1 comorbidity 3 (2.2%)
2 comorbidities 7 (5.2%)
3 comorbidities 9 (6.7%)
4 comorbidities 13 (9.6%)
5–9 comorbidities 81 (60.0%)
10? comorbidities 16 (11.7%)
Table 4 Diabetes treatment
Duration of therapy in months, mean
(standard deviation)
85.74 (89.47)




Pen, N (%) 107 (79.3%)
Vial, N (%) 27 (20.0%)
Pen and vial, N (%) 1 (0.7%)
Types of insulin
One, N (%) 106 (78.5%)
Two, N (%) 28 (20.75%)
Three, N (%) 1 (0.75%)
Number of insulin injection per day,
mean (standard deviation)
2.63 (1.69)
Concomitant use of oral antidiabetic drugs
Yes, N (%) 94 (69.6%)
No, N (%) 41 (30.4%)
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Table 5 Bivariate analysis of factors associated with the adherence to insulin, trust in physician, and PAID scores
Variable Trust in physician score PAID score Adherence score
Gender
Male 71.43 ± 19.58 28.11 ± 22.75* 78.40 ± 20.66
Female 75.23 ± 21.11 37.27 ± 21.27* 80.97 ± 19.28
Sedentary lifestyle
No 74.28 ± 20.67 30.96 ± 21.53* 81.96 ± 18.16*
Yes 68.29 ± 18.33 42.38 ± 25.04* 67.41 ± 24.77*
Residence
Urban 74.77 ± 19.17 30.44 ± 20.30 81.90 ± 15.85
Rural 71.71 ± 21.71 35.35 ± 24.47 77.18 ± 23.66
Working status
No 74.08 ± 20.35 32.24 ± 21.93 79.52 ± 20.57
Yes 71.67 ± 20.59 33.96 ± 23.72 80.10 ± 18.65
Family history of diabetes
No 73.83 ± 21.83 29.71 ± 24.12 84.77 ± 16.19**
Yes 73.15 ± 19.87 34.01 ± 21.67 77.63 ± 21.01**
Concomitant use of oral antidiabetics
No 73.66 ± 19.11 33.44 ± 23.12 78.96 ± 16.88
Yes 73.21 ± 21.01 32.45 ± 22.21 80.02 ± 21.22
Marital status
Married 73.49 ± 21.41 30.95 ± 20.98 80.48 ± 19.43
Divorced/widowed 78.11 ± 17.77 38.75 ± 25.97 78.12 ± 26.25
Single 67.55 ± 16.19 36.47 ± 25.83 77.08 ± 15.42
Educational level
Illiterate 78.66 ± 20.91* 33.05 ± 26.05 73.26 ± 28.80**
Primary 77.59 ± 20.16* 30.65 ± 19.54 82.75 ± 17.58**
Secondary 62.50 ± 19.60* 40.52 ± 25.45 74.51 ± 18.38**
University 71.88 ± 18.46* 30.11 ± 22.02 81.96 ± 18.47**
Cigarette consumption per day
Non-smoker 74.89 ± 18.83 37.01 ± 23.94** 79.63 ± 20.54
1–14 cigarettes 67.04 ± 27.97 31.69 ± 24.21** 80.35 ± 16.95
15? cigarettes 71.72 ± 22.59 25.45 ± 21.59** 76.37 ± 22.50
Former smoker 74.28 ± 18.03 30.54 ± 17.76** 82.12 ± 18.29
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element in the management of diabetes to
firstly ensure good glycemic control and also to
reduce or delay the onset of microvascular and
macrovascular complications of diabetes.
Our study showed a highly significant asso-
ciation between the degree of patients’ trust in
their doctor and treatment adherence. The
greater the degree of confidence, the greater
adherence to insulin. This result is in agreement
with the study by White et al. (2013) which
showed that adherence to therapy is directly
proportional to the degree of patient trust in the
doctor [12]. In a cross-sectional diabetes study,
older patients’ evaluations of how well their
physicians provided information on their ill-
ness and treatment were associated with patient
self-reported medication-taking behaviors
[33]. A study in the Kaiser Permanente popula-
tion found that a greater proportion of patients
who failed to initiate insulin felt that their
healthcare providers inadequately explained
the risks and benefits of insulin, compared to
those who initiated insulin [34]. More patient
counseling by healthcare professionals is nee-
ded to educate the patient about the possible
side effects that might occur with insulin
treatment and most importantly about the
efficacy of insulin [34, 35]. Emphasizing the
advantages of insulin treatment at the time of
prescribing, as well as explaining the probability
of an adverse side effect happening and its
Table 5 continued
Variable Trust in physician score PAID score Adherence score
Waterpipe consumption per week
Non-smoker 74.17 ± 20.33 30.67 ± 21.67* 80.62 ± 18.79**
Below 3 59.74 ± 25.02 55.35 ± 21.49* 60.26 ± 33.20**
3 or more 74.14 ± 21.89 48.12 ± 20.53* 81.64 ± 23.17**
Former smoker 73.18 ± 15.29 27.37 ± 21.35* 81.56 ± 13.53**
Weekly alcohol consumption
Non-drinker 73.74 ± 21.08 33.24 ± 21.73 81.51 ± 19.08
Up to one time 74.91 ± 18.87 31.34 ± 24.91 75.72 ± 21.51
More than one time 64.89 ± 22.87 36.66 ± 26.85 72.57 ± 24.98
Former drinker 73.10 ± 9.89 25.41 ± 17.35 79.16 ± 18.39
Total daily dose of insulin
Delivery device
Pen 73.49 ± 19.83 32.96 ± 22.11 80.22 ± 18.76
Vial 71.88 ± 22.63 30.74 ± 23.42 77.54 ± 24.69
Both 97.72 ± 0.00 65.00 ± 0.00 81.25 ± 0.00
Types of insulin
One 73.24 ± 20.72 33.23 ± 22.36 78.98 ± 21.24
Two 72.88 ± 19.23 29.67 ± 22.33 82.36 ± 14.51
Three 97.72 ± 0.00 65.00 ± 0.00 81.25 ± 0.00
*p\0.05; **p[0.05 but\0.2
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seriousness, may improve how patients receive
information from other sources.
Our results demonstrated that the degree of
patients’ trust in their physician was negatively
associated with the diabetes-related distress, in
line with previous findings [36] that showed
that the physician effective communication
behavior and a higher trust in him, as reported
by the patient, were inversely related to emo-
tional distress among patients with diabetes
[37]. Some interventions might be used to
increase the patient’s trust in the physician;
these include training interventions to improve
physician behavior or providing the patients
with more information about their treatment
and giving them a chance to discuss options
[38].
Furthermore, this study showed a significant
negative association between adherence to
insulin and the patient’s distress. Emotional
distress was associated with poor adherence
which is consistent with previous studies
[39, 40]. Negative, ‘‘blocking’’ thoughts
adversely impact the persons’ self-care behavior,
thereby unintentionally reinforcing a negative
cycle of events, which can ultimately lead to a
condition referred to by Polonsky as ‘‘diabetes
burnout’’ [41]. Emotional and social support
were shown to increase medication adherence
in diabetes [42] by increasing the patient’s
active coping behavior [43]. Stronger social
support from family, friends, and communities
could cultivate positive mental and emotional
changes. It strengthens patients’ resolve, belief,
and confidence in managing their condition,
and improves their quality of life [44].
Inactivity was found in our study to decrease
the adherence to insulin score, in agreement
with previous studies [45]. Physical activity
plays a vital role in the self-management of
T2DM and exercise is the best predictor of
maintaining weight, and can decrease insulin
resistance [46]. Fear of hypoglycemia is one of
the factors that could prevent the patient from
performing any physical activity. In the present
study, participants with a higher awareness of
hypoglycemia risk were more prone to reduce
their physical activity. This is consistent with
the finding of the study done in Scotland which
stated that main reason for inactivity is due to
fear of hypoglycemia [47].
A secondary level of education was nega-
tively associated with a decrease in the trust in
physician score. This might be explained by the
fact that patients with higher educational
attainment are more involved in the medical
decision-making process and verify the credi-
bility of information provided by their physi-
cian and sometimes explore options beyond
what is given during their medical visit [48].











1 - 0.289* 0.416*
PAID score - 0.289* 1 - 0.300*
Adherence score 0.416* - 0.300* 1
Age 0.078 - 0.071 - 0.044








0.086 - 0.031 0.081
Number of
comorbidities
0.048 - 0.104 - 0.068
Duration of
insulin therapy
0.133** - 0.239* 0.000
Total insulin
daily dose








0.167** - 0.123** 0.137**
*p\0.05; **p[0.05 but\0.2
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People with a lower literacy level may be more
willing to trust their physician and accept their
recommendations without questioning them.
Smoking waterpipe was negatively associated
with adherence to treatment but positively
associated with the diabetes-related distress, in
line with the study by Solberg et al. [49] who
found that smokers with diabetes report more
sadness or depression compared to non-smokers
with diabetes [49]. Waterpipe smoking being
associated with a decrease in adherence to
treatment is similar to the findings of Ciecha-
nowski et al. [50] but opposite to those of Sol-
berg et al. [49].
This study also showed that patients who do
not have a family history of diabetes were more
adherent to insulin than patients with a family
history of diabetes, in agreement with the
findings of Riaz et al. [45]. This can be attributed
to the higher vigilance of these patients about
their disease and the fear of future complica-
tions and their impact on their quality of life.
On the other hand, our study showed no asso-
ciation between adherence and gender, age,
diabetes duration since diagnosis, and the
patient’s level of education, consistent with
several previous studies [23, 51–53].
Limitations
Our study has a number of limitations. The total
sample size is small and might not be repre-
sentative of the whole population. This is a
cross-sectional self-designed survey with retro-
spective reports, and consequently a low level of
evidence. The effect of the recall bias could be
differential and lead to the overestimation of
effects for some known risk factors. An infor-
mation bias is also possible since the use of a
questionnaire may not always be accurate:
problems in question understanding, recall
deficiency, and over- or underevaluating symp-
toms may still be possible. In addition, the cost
of medications, a factor known to affect adher-
ence, was not taken into consideration even
though we think that it may not have been a
strong bias in this study because 88% of the
patients had either private insurance or social
security paying for their medications.







Linear regression 1 taking the trust in physician score as the dependent variable
Secondary level of education (compared to illiteracy) - 13.486 - 0.262 0.002 - 21.913 - 5.059
Total number of oral antidiabetics 0.934 0.169 0.043 0.028 1.840
Linear regression 2 taking the adherence score as the dependent variable
Sedentary lifestyle - 12.739 - 0.232 0.006 - 21.814 - 3.663
Less than 3 waterpipes per week compared to no
waterpipe smoking
- 16.826 - 0.188 0.027 - 31.660 - 1.991
Linear regression 3 taking the PAID score as the dependent variable
Less than 3 waterpipes per week compared to no
waterpipe smoking
27.426 0.273 0.001 11.221 43.632
Gender 10.467 0.234 0.005 3.267 17.667
3 or more waterpipes per week compared to no
waterpipe smoking
17.951 0.191 0.020 2.815 33.087
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CONCLUSION
Patient adherence to insulin is an important
criterion for achieving the desired therapeutic
outcomes in diabetes management. Distress in
diabetes shows a negative association with
adherence. Good healthcare professional–pa-
tient communication is a major expectation
and an important parameter improving drug
adherence. It determines the patients’ trust in
their physician, thus improving adherence.
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